deltatrials
Unknown OBSERVATIONAL NCT05642104

The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy

Sponsor: Beijing Shijitan Hospital, Capital Medical University

Interventions Neoadjuvant therapy
Updated 4 times since 2023 Last updated: Dec 6, 2022 Started: Oct 1, 2021 Primary completion: Oct 1, 2023 Completion: Oct 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Neoplasms, this trial is ongoing. The trial is conducted by Beijing Shijitan Hospital, Capital Medical University and has accumulated 4 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 21 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Dec 2024 — Present [monthly]

    Unknown

    Status: RecruitingUnknown

  2. Sep 2024 — Dec 2024 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Jan 2023 — Jul 2024 [monthly]

    Recruiting

    First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Shijitan Hospital, Capital Medical University
Data source: Beijing Shijitan Hospital, Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations